Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited allogeneic CAR T-cells (UCART). By capitalizing on its 18 years of expertise in gene editing – built on its flagship TALEN® technology and pioneering electroporation system PulseAgile – Cellectis uses the power of the immune system to target and eradicate cancer cells.
Cellectis SA, based in Paris, France, is seeking a Process Development Technician for a permanent contract. This position is focused on the development of manufacturing processes for various cellular products.
Within the team, the candidate will be in charge of setting up and carrying out the experiments leading to the validation of the manufacturing process(es) for UCART cellular products. The methods will be developed at the final production scale with all the necessary instruments (bioreactors, cell separators etc.) and will lead to the standard processes that will be implemented for the production of clinical batches.
The candidate must have a real autonomy, the ability to work within a team, a strong motivation, flexibility in the nature of the work carried out, he/she should be a force of proposals and excel respecting the objectives and the deadlines which are fixed.
Qualifications and experience
Cellectis is listed on the Alternext Market (code: ALCLS) and on the Nasdaq Global Market (code:CLLS). For further information please visit our website: www.cellectis.com
Applicants should submit their CV and motivation letter at the following address: CLS_TPD_2018-09_SLS@cellectis.com or directly on our website: http://cellectis.com/en/careers/current-vacancies/process-development-technician/